"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Post-Antibiotic Effect (PAE): Mechanism, Examples, and Clinical Importance


Definition of Post-Antibiotic Effect

The Post-Antibiotic Effect (PAE) is the phenomenon where bacterial growth remains suppressed even after a brief exposure to an antibiotic, once the drug concentration falls below the minimum inhibitory concentration (MIC). This effect prevents the regrowth of bacteria, even at reduced or absent antibiotic levels.


Mechanism

  • Prolonged bacterial recovery time following antibiotic exposure.
  • Persistence of antibiotic-induced damage to bacterial cell targets.
  • Extended suppression of essential bacterial protein synthesis.

Examples of Drugs with PAE

  • Aminoglycosides (e.g., gentamicin, tobramycin): Effective PAE against Gram-negative bacteria, especially with high doses.
  • Fluoroquinolones (e.g., ciprofloxacin, levofloxacin): Show PAE against both Gram-positive and Gram-negative bacteria.
  • Macrolides (e.g., azithromycin, clarithromycin): Known for PAE against certain Gram-positive organisms.
  • Beta-lactams (e.g., penicillins, cephalosporins): Typically do not exhibit a long PAE. Their effects are more related to continuous exposure above the MIC.

Clinical Importance

  • Extended Dosing Intervals: PAE allows for fewer doses, reducing the need for continuous drug presence. This is particularly beneficial in aminoglycosides, where high doses can be administered less often to avoid toxicity.
  • Improved Patient Compliance: Fewer doses per day improve patient adherence, especially in outpatient settings where frequent dosing may be challenging.
  • Decreased Resistance Risk: PAE minimizes bacterial exposure to sub-therapeutic levels, reducing the chance for bacteria to develop resistance.

© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed